SCHEMBL355066

SCHEMBL355066

CCC(C)(N)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16115944 0.97
Stearic Acid SCHEMBL29066955 0.78 GPR84 (0.61)
SCHEMBL2380994 0.78
SCHEMBL27650206 0.78
SCHEMBL23240782 0.77
SCHEMBL23348 0.77
SCHEMBL23350 0.77
SCHEMBL2354822 0.77
SCHEMBL23349 0.77
SCHEMBL2030470 0.77 GGT1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928867-B1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS HOFFMANN LA ROCHE (CH) 2017-08-09 EP claimed
US-9409866-B2 Pyridine-2-amides useful as CB2 agonists HOFFMANN-LA ROCHE INC. (US) 2016-08-09 US claimed
US-20150344429-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2015-12-03 US claimed
US-5583257-A REDUCING AGENTS FOR PERMANENT HAIR; ODORLESS L'OREAL (FR) 1996-12-10 US claimed
EP-3302441-B1 PROCESSES TO PRODUCE BRIVARACETAM SUZHOU PENGXU PHARMATECH CO LTD (CN) 2023-12-13 EP disclosed
EP-3604457-B1 AQUEOUS INK COMPOSITION, INK SET, IMAGE FORMING METHOD, AND RESIN MICROPARTICLES FOR INK FUJIFILM CORP (JP) 2022-02-09 EP disclosed
WO-2019181840-A1 AQUEOUS INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD 富士フイルム株式会社 2019-09-26 WO disclosed
US-10221134-B2 Processes to produce brivaracetam ESTEVE QUIMICA S.A. (ES) 2019-03-05 US disclosed
CN-106349156-B It can be used as the pyridine -2- amides of CB2 agonist 霍夫曼-拉罗奇有限公司 2018-12-11 CN disclosed
US-20180155284-A1 PROCESSES TO PRODUCE BRIVARACETAM ESTEVE QUIMlCA S.A. (ES) 2018-06-07 US disclosed
EP-3072886-B1 PYRIDIN-2-AMIDES USEFUL AS CB2 AGONISTS HOFFMANN LA ROCHE (CH) 2018-04-18 EP disclosed
CN-105585505-B Novel preparation method of anergotaine intermediate 1, 2-diamino-2-methylpropane 辽宁本源制药有限公司 2017-10-31 CN disclosed
EP-0765879-A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO COMPANY LIMITED (JP) 1997-04-02 EP disclosed
US-5614470-A AGRICULTURAL ANTHELMINTIC, ACARICIDE, INSECTICIDE SANKYO COMPANY, LIMITED (JP) 1997-03-25 US disclosed
US-5583257-A REDUCING AGENTS FOR PERMANENT HAIR; ODORLESS L'OREAL (FR) 1996-12-10 US disclosed
EP-0675133-A1 13-Substituted milbemycin derivatives, their preparation and use SANKYO COMPANY LIMITED (JP) 1995-10-04 EP disclosed
US-5449805-A Permanent waves for hair L'OREAL (FR) 1995-09-12 US disclosed
US-5373000-A Antibacterial agent against both grampositive and gramnegative bacterias EISAI CO., LTD. (JP) 1994-12-13 US disclosed
US-5334377-A Reduction of the disulfide bond of keratin; the oxidation L'OREAL (FR) 1994-08-02 US disclosed
EP-0227967-A2 Imidazoline derivatives, process for preparing same, herbicide containing same, and plant growth regulator containing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1987-07-08 EP disclosed